Actively Recruiting

Early Phase 1
Age: 18Years +
All Genders
NCT06276686

Exercise for Improving Long-course Chemoradiotherapy Efficacy in People With Locally Advanced Rectal Cancer

Led by University of Hull · Updated on 2025-02-04

30

Participants Needed

1

Research Sites

63 weeks

Total Duration

On this page

Sponsors

U

University of Hull

Lead Sponsor

H

Hull University Teaching Hospitals NHS Trust

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a single arm feasibility study of exercise for improving long- course neoadjuvant chemoradiotherapy (NACRT) efficacy in people diagnosed with locally advanced rectal cancer. The study aims to recruit up to 30 patients from the Queen's Centre for Oncology and Haematology of Castle Hill Hospital, Cottingham, diagnosed with locally advanced rectal cancer. Consenting patients will be provided with an 11-week course of structured aerobic exercises and resistance training in the periods before, during and after their chemoradiotherapy treatment. The patients will be followed up for 6 months post long course neoadjuvant chemoradiotherapy (NACRT), with a total of 3 assessment periods.

CONDITIONS

Official Title

Exercise for Improving Long-course Chemoradiotherapy Efficacy in People With Locally Advanced Rectal Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years or older
  • Diagnosed with locally advanced rectal cancer confirmed by MRI and histology
  • Offered long-course neoadjuvant chemoradiotherapy at the Queens Centre, Castle Hill Hospital
  • Willing and able to follow all study requirements
  • Able and willing to give informed consent voluntarily
Not Eligible

You will not qualify if you...

  • Unable to understand basic written and spoken English
  • Movement issues limiting ability to exercise
  • Impaired cognition or capacity affecting informed consent
  • Cardiovascular or cardiopulmonary conditions preventing safe exercise
  • Severe psychiatric disorders
  • Any health condition deemed by oncologists and research team to prevent safe exercise
  • Presence of metastatic cancer

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Castle Hill Hospital

Cottingham, East Yorkshire, United Kingdom, HU16 7JQ

Actively Recruiting

Loading map...

Research Team

C

Chizitara Amadi

CONTACT

J

John Saxton

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here